Nuclear Medicine: Page 109

Dilon, GE ink distribution deal

By AuntMinnie.com staff writers

Molecular breast imaging developer Dilon Diagnostics has signed on to be the exclusive distributor of GE Healthcare's Discovery NM750b molecular breast imaging system in North America.

November 15, 2016

Lantheus Holdings plans stock offering

By AuntMinnie.com staff writers

Lantheus Holdings, the parent company of Lantheus Medical Imaging, said it will sell 3 million shares of its common stock in a public offering.

November 15, 2016

International Isotopes sees revenue dip in Q3

By AuntMinnie.com staff writers

A drop in revenues in its radiological services and cobalt product segments led to a 12% decline in revenues for radioisotope manufacturer International Isotopes in its third quarter.

November 14, 2016

PET/CT of coronary calcium | Deep learning and elastography | 4D CT of ankle instability

By Brian Casey

November 14, 2016

PET/CT of calcium forewarns of adverse cardiac event

By Wayne Forrest

Patients with a normal stress test but evidence of calcium in coronary arteries on PET/CT scans are not immune from a serious adverse cardiac event within a year, according to a study presented on Monday at the American Heart Association annual meeting in New Orleans.

November 14, 2016

Australia offers update on medical isotope production

By AuntMinnie.com staff writers

Australia is ready to pitch in to help ensure the world has enough medical isotopes following the end of production last week at the National Research Universal nuclear reactor in Chalk River, Ontario.

November 10, 2016

Eckert & Ziegler posts 9-month financial results

By AuntMinnie.com staff writers

Isotope technology firm Eckert & Ziegler has posted financial results for the nine-month period ending 30 September.

November 3, 2016

JNM: Florbetaben-PET detects cardiac amyloidosis

By Wayne Forrest

Australian researchers have shown the proficiency of PET with the radiotracer F-18 florbetaben to detect abnormal deposits of proteins in the heart in a study published in the November issue of the Journal of Nuclear Medicine.

November 3, 2016

Navidea posts Q3 revenue increases

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals posted revenue increases and lower net losses in the third quarter of 2016, part of which it attributed to sales growth of its Lymphoseek radiopharmaceutical and a milestone payment from Cardinal Health.

November 2, 2016

Gamma Medica brings MBI to Henry Ford

By AuntMinnie.com staff writers

Molecular imaging developer Gamma Medica has taken an order for its LumaGem molecular breast imaging (MBI) system from Henry Ford Health System in Detroit.

November 2, 2016

Novel PET compound could aid Alzheimer's detection

By Wayne Forrest

Researchers at Washington University School of Medicine in St. Louis have developed a chemical compound that detects amyloid deposits on PET scans better than currently approved imaging agents, according to a paper published November 2 in Scientific Reports.

November 2, 2016

Lantheus posts flat Q3 results despite US contrast growth

By AuntMinnie.com staff writers

Strong U.S. sales of its Definity ultrasound contrast agent and stable revenues from U.S. nuclear products helped Lantheus Holdings offset international doldrums in the company's third-quarter financial report.

November 1, 2016

Previous Page

Page 109 of 445

Next Page